Search Results - "Riethmueller, J"

90 Inhalation of colistimethate dry powder (Colobreathe) results in negligible systemic exposure by Riethmueller, J, Goldman, M, Turay, P

Get full text

CD95/CD95 Ligand Interactions on Epithelial Cells in Host Defense to Pseudomonas aeruginosa by Grassmé, Heike, Kirschnek, Susanne, Riethmueller, Joachim, Riehle, Andrea, von Kürthy, Gabriele, Lang, Florian, Weller, Michael, Gulbins, Erich

“…Pseudomonas aeruginosa causes severe infections, particularly of the lung, that are life threatening. Here, we show that P. aeruginosa infection induces…”
Get full text

Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients by Riethmueller, J, Ballmann, M, Schroeter, T. W, Franke, P, von Butler, R, Claass, A, Junge, S, Doering, G, Stern, M

“…Purpose: We hypothesized that a single intravenous (iv) tobramycine infusion (treatment B) would have equivalent anti-infectious efficacy in chronic…”
Get full text

Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis by Riethmueller, J, Junge, S, Schroeter, T. W, Kuemmerer, K, Franke, P, Ballmann, M, Claass, A, Broemme, S, Jeschke, R, Hebestreit, A, Staab, D, Koetz, K, Doering, G, Stern, M

“…Background/aim: We hypothesized that a continuous 24-h infusion of 100 mg/kg per day ceftazidime (treatment C) would result in equivalent or even superior…”
Get full text

157 Long-term impact of fungi on pediatric cystic fibrosis lung disease by Hector, A, Berenbrinker, S, Kirn, T, Graepler-Mainka, U, Riethmueller, J, Kappler, M, Griese, M, Hartl, D

Get full text

WS19.5 Characterization of fungal colonization phenotypes in pediatric cystic fibrosis lung disease by Graepler-Mainka, U, Berenbrinker, S, Hector, A, Riethmueller, J, Stern, M, Hartl, D

Get full text

356 Antifungal treatment in cystic fibrosis patients infected with Aspergillus fumigatus stabilizes pulmonary function by Graepler-Mainka, U, Hector, A, Riethmueller, J, Stern, M, Hartl, D

Get full text

91 Sequential inhalative tobramycin–colistin-combination stabilizes patients with chronic Pseudomonas aeruginosa colonization by Herrmann, G, Hellwig, D, Heuer, H.-E, Heyder, S, Köster, H, Kröger, K, Paul, K, Mellies, U, Schmitt, A, Wagenseil, D, Riethmueller, J

Get full text

WS5.6 Regulatory T cells in cystic fibrosis patients infected with Pseudomonas aeruginosa by Hector, A, Schäfer, H, Pöschel, S, Bakele, M, Rieber, N, Carevic, M, Hogardt, M, Neri, D, Graepler-Mainka, U, Riethmueller, J, Stern, M, Hartl, D

Get full text

WS19.9 A prospective multicenter study to dissect Staphylococcus aureus-colonization from infection in cystic fibrosis patients by Junge, S, Wiedemann, B, Tümmler, B, Dübbers, A, Küster, P, Nofer, J, Ellemunter, H, Mainz, J.G, Heuer, E, Sextro, W, Körner-Rettberg, C, Ballmann, M, Mellies, U, Hammermann, J, Teschler, H, Szczepanski, R, Tegtmeyer, F.K, Graepler-Mainka, U, Riethmueller, J, Wald, A, Wollschläger, B, Staab, D, Schuster, A, Becker, K, Peters, G, Kahl, B.C

Get full text

WS6.2 Anti-inflammatory pulmonal therapy of CF patients with amitriptyline and placebo – a randomised, double-blind, placebo-controlled Phase IIb multicenter cohort study by Adams, C, Mainz, J.G, Naehrlich, L, Engel, C, Herrmann, G, Icheva, V, Graepler-Mainka, U, Heyder, S, Stern, M, Döring, G, Gulbins, E, Riethmueller, J

Get full text

WS2.9 Expression and regulation of IFRD1 in neutrophils of cystic fibrosis patients by Hector, A, Kormann, M.S.D, Rieber, N, Mays, L, Marcos, V, Graepler-Mainka, U, Stern, M, Riethmueller, J, Döring, G, Kappler, M, Griese, M, Hartl, D

Get full text

Lung clearance index vs. FEV1 in healthy adults and patients with cystic fibrosis by Pantalitschka, T, Rueckel, H, Walter, T, Riethmueller, J, Hofbeck, M, Baden, W

Get full text

Microstructure and mechanical behavior of Pt-modified NiAl diffusion coatings by Riethmueller, J., Dehm, G., Affeldt, E. E., Arzt, E.

“…The performance of thermal barrier coatings (TBCs) in jet engines is strongly influenced by thermal and mechanical properties of the bond coat. In this…”
Get full text

Microstructure and mechanical behavior of Pt-modified NiAl diffusion coatings by Riethmueller, J., Dehm, G., Affeldt, E. E., Arzt, E.

“…The performance of thermal barrier coatings (TBCs) in jet engines is strongly influenced by thermal and mechanical properties of the bond coat. In this…”
Get full text

Home and hospital antibiotic Treatment prove similarly effective in cystic fibrosis by RIETHMUELLER, J, BUSCH, A, DAMM, V, ZIEBACH, R, STERN, M

“…Home intravenous antibiotic treatment has added to therapeutic options against Pseudomonas aeruginosa in cystic fibrosis (CF) patients leading to increased…”
Get full text

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial by De Boeck, K, Haarman, E, Hull, J, Lands, LC, Moeller, A, Munck, A, Riethmüller, J, Tiddens, H, Volpi, S, Leadbetter, J, Charlton, B, Malfroot, A

“…Abstract Introduction Inhaled mannitol has beneficial effects on lung function, mucociliary clearance, quality of life and sputum properties. This trial…”
Get full text

Influence of rhDNAse on the duration of mechanical ventilation in intensive care patients by Deschner, N, Friedrich, B, Brehm, W, Vonthein, R, Riethmueller, J

Get full text

Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Young, Mechanically Ventilated Children by Riethmueller, Joachim, Borth-Bruhns, Thomas, Kumpf, Matthias, Vonthein, Reinhard, Wiskirchen, Jakub, Stern, Martin, Hofbeck, Michael, Baden, Winfried

“…Recombinant human deoxyribonuclease I (dornase alfa) is currently used as an inhaled mucoactive agent in the treatment of cystic fibrosis. In a randomized,…”
Get full text

Influence of rhDNAse on the duration of mechanical ventilation in intensive care patients: ESAPC1-3 by Deschner, N., Brehm, W., Vonthein, R., Riethmueller, J.

Get full text